Table 1.
Demographics, baseline characteristics, and clinical features of 310 patients infected with the SARS-CoV-2 B.1.1.529 (Omicron) variant.
| Characteristics | No. (%) of patients |
|---|---|
| Age groups(y) | |
| ≤ 18 | 94 (30.32) |
| 19–44 | 101 (32.58) |
| 45–64 | 90 (29.03) |
| ≥ 65 | 25 (8.06) |
| Gender | |
| Male | 136 (43.87) |
| Female | 174 (56.13) |
| Vaccination | |
| Without record | 5 (1.61) |
| Unvaccinated | 20 (6.45) |
| 1 Dose | 16 (5.16) |
| 2 Doses | 160 (51.61) |
| 3 Doses | 109 (35.16) |
| Clinical classifications | |
| Asymptomatic | 10 (3.23) |
| Mild | 179 (57.74) |
| Moderate | 118 (38.06) |
| Severe | 3 (0.97) |
| Laboratory findings | |
| IgG | 20.17 (44.05) |
| IgM | 26.58 (49.37) |
| Symptoms | |
| Fever | 122 (39.35) |
| Cough | 151 (48.71) |
| Sore Throat | 118 (38.26) |
| Feeble | 29 (9.35) |
| Headache | 21 (6.78) |
| Muscular Soreness | 16 (5.16) |
| Stuffy Nose | 28 (9.03) |
| Running Nose | 31 (10.00) |
| Taste Loss | 2 (0.65) |
| Anosmia | 5 (1.61) |
| Diarrhea | 10 (3.23) |
Note: Data are shown as number (%) or mean (standard deviation).